These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7868490)

  • 1. Effect of rifampicin on theophylline pharmacokinetics in human beings.
    Rao S; Singh SK; Narang RK; Rajagopalan PT
    J Assoc Physicians India; 1994 Nov; 42(11):881-2. PubMed ID: 7868490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics.
    Ahn HC; Yang JH; Lee HB; Rhee YK; Lee YC
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):784-7. PubMed ID: 10949332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers.
    Adebayo GI; Akintonwa A; Mabadeje AF
    Eur J Clin Pharmacol; 1989; 37(2):127-31. PubMed ID: 2792166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampicin administration on theophylline pharmacokinetics in humans.
    Powell-Jackson PR; Jamieson AP; Gray BJ; Moxham J; Williams R
    Am Rev Respir Dis; 1985 Jun; 131(6):939-40. PubMed ID: 4003946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
    Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
    Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
    Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of isradipine on theophylline pharmacokinetics in healthy volunteers.
    Perreault MM; Kazierad DJ; Wilton JH; Izzo JL
    Pharmacotherapy; 1993; 13(2):149-53. PubMed ID: 8469622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of drug-metabolizing activity in the human liver by interferon-beta.
    Okuno H; Takasu M; Kano H; Seki T; Shiozaki Y; Inoue K
    Hepatology; 1993 Jan; 17(1):65-9. PubMed ID: 8423043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
    Górnik W
    Ann Acad Med Stetin; 1996; 42():39-50. PubMed ID: 9199125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bioavailability of a new theophylline chewable pill].
    Staib AH; Mäuser R; Zaigler M; Fuhr U
    Pneumologie; 1997 Jun; 51(6):560-3. PubMed ID: 9333788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline-rifampicin interaction: non-selective induction of theophylline metabolic pathways.
    Robson RA; Miners JO; Wing LM; Birkett DJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):445-8. PubMed ID: 6487483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of rifampicin on the pharmacokinetics of tolbutamide in healthy subjects].
    Zilly W; Bopp E; Bürkl B; Richter E
    Verh Dtsch Ges Inn Med; 1974; 80():1538-40. PubMed ID: 4454477
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
    Warrington SJ; Johnston A; Lewis Y; Murphy M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY; Kim KA; Park PW; Park CW; Shin JG
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline in obesity.
    Zahorska-Markiewicz B; Waluga M; Zieliñski M; Klin M
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):393-5. PubMed ID: 8880289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats.
    Tang J; Sun J; Zhang Y; Li L; Cui F; He Z
    Food Chem Toxicol; 2007 Dec; 45(12):2441-5. PubMed ID: 17681658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.